Pulmicort Overview and Dosage Information

Study Notes

Pulmicort (Budesonide) Overview

Generic name for Pulmicort is budesonide.
Designed for inhalation to manage respiratory conditions.

Dosage Information

Available as DPI (Dry Powder Inhaler).
Dosage options include 90 mcg and 180 mcg per actuation.
Recommended usage is Q12 with one puff.

Drug Classification

Classified as a corticosteroid, which helps reduce inflammation in the airways.

Contraindications

Not suitable for patients with status asthmaticus or acute asthma.
Should be avoided in cases of acute bronchospasms.
Contraindicated for those with glaucoma, immunosuppression, hepatic impairment, or hypersensitivity to milk proteins.

Hazards of Use

Potential hazards include oral thrush, slow growth in children, and respiratory symptoms such as cough and nasal issues.
Risk of ear infections may also be increased.

Side Effects

Long-term use may lead to reduced bone density.
Possible ocular side effects include glaucoma and cataracts.
May cause paradoxical bronchospasm and adrenal suppression in some patients.

Mechanism of Action

Functions by blocking inflammation through the glucocorticoid receptor, effectively decreasing airway inflammation.

Inhaler Type

Pulmicort is a dry powder inhaler (DPI), which administers medication in a powdered form for inhalation.

Description

This quiz covers essential information about Pulmicort (budesonide), including its classification as a corticosteroid and its safe usage for respiratory conditions. Learn about the available dosage options, contraindications, potential hazards, and side effects associated with this medication.